Extreme and unjustified price hikes on generic drugs "are part of the broad strategy by the pharmaceutical industry to increase the prices of patented and generic drugs by double-digit figures annually (10-12 percent)," writes fellow Hagop Kantarjian, who chairs the Department of Leukemia at MD Anderson Cancer Cancer. Kantarjian offers five immediate steps the government can take to lower drug prices. The Hill: http://bit.ly/2l0Sg3Q
